This inventor holds 5 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Autotac Inc., Lg Electronics Inc., Seoul National University. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 8 
1 out of 51,857 
1 out of 1,789 
Years Active: 2024-2025
Title: Innovations and Contributions of Inventor Hee Yeon Kim
Introduction: Hee Yeon Kim is an accomplished inventor based in Seoul, South Korea, known for her significant contributions to the field of biotechnology. With a total of two patents to her name, she has developed cutting-edge compounds aimed at enhancing therapeutic efficacy through innovative mechanisms.
Latest Patents: Hee Yeon Kim's latest patents include the AUTOTAC chimeric compound and a composition for preventing, ameliorating, or treating diseases through targeted protein degradation. The AUTOTAC chimeric compound is a novel creation, linking a new p62 ligand and a target-binding ligand via a linker, which can serve as an effective pharmaceutical composition. This compound enables selective elimination of specific proteins, adjusting their concentrations and facilitating the delivery of drugs to lysosomes for disease treatment. Furthermore, her p62 ligand compound serves as a pharmaceutical composition aimed at activating autophagy in cells, which is pivotal in selectively removing proteins and aggregates associated with various proteinopathies.
Career Highlights: Hee Yeon Kim is a proud member of Autotac Inc., where she contributes her expertise in the development of innovative therapeutic strategies. Her work has been instrumental in positioning the company at the forefront of protein degradation technologies, enabling new pathways for disease intervention.
Collaborations: Throughout her career, Hee Yeon Kim has collaborated with distinguished colleagues such as Yong Tae Kwon and Chang Hoon Ji. These collaborations have not only enriched her research experience but have also amplified the impact of her innovations in the field of biotechnology.
Conclusion: Hee Yeon Kim's inventive spirit and dedication to scientific advancement have led to groundbreaking patents that promise to revolutionize approaches to disease treatment. Her innovative contributions exemplify the vital role of inventors in advancing healthcare and improving patient outcomes through targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile